Content-type: text/application/x-research-info-systems

TY  - JOUR
AU  - Bae, S I
AU  - Cheriyath, V
AU  - Jacobs, B S
AU  - Reu, F J
AU  - Borden, E C
TI  - Reversal of methylation silencing of Apo2L//TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L//TRAIL
JA  - Oncogene
PY  - 2007/07/23/online
VL  - 27
IS  - 4
SP  - 490
EP  - 498
PB  - Nature Publishing Group
SN  - 0950-9232
UR  - http://dx.doi.org/10.1038/sj.onc.1210655
L3  - http://www.nature.com/onc/journal/v27/n4/suppinfo/1210655s1.html
ER  -